New England Journal of Medicine
The New England Journal of Medicine is a leading medical journal providing research, reviews, and commentary on clinical practice and biomedical science.
Parkinson’s Disease | New England Journal of Medicine
Jul 31, 2024 · Parkinson’s disease is a multisystem neurodegenerative disorder with motor and prominent, sometimes premonitory, nonmotor symptoms. Detection of gene variants may inform prognosis and ...
Rheumatoid Arthritis — Common Origins, Divergent Mechanisms
Feb 8, 2023 · Rheumatoid arthritis is a chronic, systemic autoimmune disease manifested primarily as inflammatory arthritis, typically involving the small joints of the hands and feet. It can lead to severe disa...
Climate Change, Extreme Heat, and Health | NEJM
May 15, 2024 · The frequency, duration, and intensity of heat waves in the United States have increased in recent decades ().The annual number of heat waves is now twice that in the 1980s, and the heat wave ...
Long Covid Defined | New England Journal of Medicine
Jul 31, 2024 · Members of the National Academies of Sciences, Engineering, and Medicine describe the process and rationale for the development of the 2024 definition of persistent Covid-19 symptoms (long Covid).
Management of Insomnia | New England Journal of Medicine
Jul 17, 2024 · Insomnia is common and frequently occurs with other disorders. First-line cognitive behavioral therapy with or without medication can produce rapid, sustained alleviation of insomnia symptoms.
Effect of Early Treatment with Ivermectin among Patients with …
Mar 30, 2022 · One drug that has received considerable public use and interest is ivermectin, which is typically used as an antiparasitic drug. Ivermectin inhibits the chloride channels of helminthic parasites ...
Pulmonary Embolism | New England Journal of Medicine
Jul 6, 2022 · Pulmonary embolism occurs when embolic venous thrombi are caught within the branching lung vasculature. These thrombi often develop within the leg or pelvic veins, and approximately half of all ...
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Feb 10, 2021 · Semaglutide is a glucagon-like peptide-1 (GLP-1) analogue that is approved, at doses up to 1 mg administered subcutaneously once weekly, for the treatment of type 2 diabetes in adults and for ...
Coffee, Caffeine, and Health | New England Journal of Medicine
Jul 22, 2020 · Coffee and tea are among the most popular beverages worldwide and contain substantial amounts of caffeine, making caffeine the most widely consumed psychoactive agent. 1 A variety of plants ...